US Patent Issued to Oyster Point Pharma on June 16 for "Compositions and use of varenicline for treating dry eye" (Nevada, Massachusetts, Texas Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,824, issued on June 16, was assigned to Oyster Point Pharma Inc. (Morgantown, W.va.).

"Compositions and use of varenicline for treating dry eye" was invented by Douglas Michael Ackermann Jr. (Reno, Nev.), James Loudin (Houston) and Kenneth J. Mandell (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods and pharmaceutical formulations for treating dry eye disease."

The patent was filed on April 3, 2025, under Application No. 19/169,836.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearc...